Oramed Pharmaceuticals (FRA:OJU1) OCF Margin %: 0.00% (As of Mar. 2026)

What is Oramed Pharmaceuticals OCF Margin %?

Oramed Pharmaceuticals FRA:OJU1 +16.18% 34 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:OJU1 with a GF Score™ of 34/100. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Oramed Pharmaceuticals ranks worse than 70.91% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Oramed Pharmaceuticals's Cash Flow from Operations for the three months ended in Mar. 2026 was €-2.52 Mil. Oramed Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Oramed Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Oramed Pharmaceuticals's current OCF Yield % is -4.86%.

The historical rank and industry rank for Oramed Pharmaceuticals's OCF Margin % or its related term are showing as below:

FRA:OJU1' s OCF Margin % Range Over the Past 10 Years
Min: -1032.85 Med: -478.73 Max: 726.21
Current: -431.38

During the past 13 years, the highest OCF Margin % of Oramed Pharmaceuticals was 726.21%. The lowest was -1032.85%. And the median was -478.73%.

FRA:OJU1's OCF Margin % is ranked worse than
70.91% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs FRA:OJU1: -431.38

Oramed Pharmaceuticals OCF Margin % Related Terms

Oramed Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Oramed Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oramed Pharmaceuticals OCF Margin % Chart

Oramed Pharmaceuticals Annual Data

Trend

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

-783.46

-1,032.72

-768.19

0.00

-457.26

Oramed Pharmaceuticals Quarterly Data
	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															-175.95	0.00	0.00	0.00	0.00

FRA:OJU1 vs SPRO, PLYX, HRTX: OCF Margin % Comparison

For the Biotechnology subindustry, Oramed Pharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oramed Pharmaceuticals OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oramed Pharmaceuticals's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Oramed Pharmaceuticals's OCF Margin % falls into.

Save Embed

34GF Score

Oramed Pharmaceuticals Inc FRA:OJU1

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Oramed Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Oramed Pharmaceuticals's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-7.81	/	1.708
	=	-457.26 %

Oramed Pharmaceuticals's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-2.521	/	0
	=	%

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of 0.00% mean?

Oramed Pharmaceuticals (FRA:OJU1) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Oramed Pharmaceuticals and its competitors. According to the industry distribution chart, Oramed Pharmaceuticals ranks #680 out of 959 companies in the Biotechnology industry, placing it in the top 70.9%.

Is Oramed Pharmaceuticals' OCF Margin % too high?

Oramed Pharmaceuticals' current OCF Margin % is 0.00%. Based on the distribution chart, Oramed Pharmaceuticals ranks #680 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Oramed Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.

How does Oramed Pharmaceuticals' OCF Margin % compare to SPRO and PLYX?

According to the Biotechnology industry distribution chart, Oramed Pharmaceuticals ranks #680 out of 959 companies for OCF Margin %. This places Oramed Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Oramed Pharmaceuticals and its competitors. Oramed Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Oramed Pharmaceuticals stock overvalued right now?

Oramed Pharmaceuticals (FRA:OJU1) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Oramed Pharmaceuticals' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Oramed Pharmaceuticals (FRA:OJU1), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oramed Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies SPRO PLYX HRTX MENS NRXP PRQR GALT PLX CNTB ANTX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges ORMP:USA ORMP:Israel OJU1:Germany

Address 1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036

Website https://www.oramed.com

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

34GF Score

Get the complete analysis for FRA:OJU1

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.20

Price

View FRA:OJU1 Analysis

See OCF Margin % data for all stocks →